343 related articles for article (PubMed ID: 26681145)
1. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
4. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.
Wittström E; Holmberg H; Hvarfner C; Andréasson S
Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.
Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K
J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888
[TBL] [Abstract][Full Text] [Related]
8. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma.
Sahyoun M; Azar G; Khoueir Z; Antoun J; Kourie H; Nehme J; Jalkh A
J Glaucoma; 2015; 24(5):383-8. PubMed ID: 25719230
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma.
Mahdy RA; Nada WM; Fawzy KM; Alnashar HY; Almosalamy SM
J Glaucoma; 2013 Dec; 22(9):768-72. PubMed ID: 22790513
[TBL] [Abstract][Full Text] [Related]
13. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
15. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
Fong AW; Lee GA; O'Rourke P; Thomas R
Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for neovascular glaucoma.
Vasudev D; Blair MP; Galasso J; Kapur R; Vajaranant T
J Ocul Pharmacol Ther; 2009 Oct; 25(5):453-8. PubMed ID: 19857107
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
[TBL] [Abstract][Full Text] [Related]
18. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
[TBL] [Abstract][Full Text] [Related]
20. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
Nagendran ST; Finger PT
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
